Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial - Concepedia

Concepedia

Publication | Open Access

Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial

DOI Full Paper Access

41

Citations

24

References

2021

Year

Hong Zhao, Chi Zhang, Qi Zhu, Xianxiang Chen, Guilin Chen, Wenjin Sun, Zuohan Xiao, Wei-Jun Du, Jing Yao, Guojun Li,

International Immunopharmacology

Antiviral Drug DevelopmentAntiviral TherapyVirologyRandomized TrialAntiviral DrugMedicineCovid-19Sars-cov-2 Rna Recurrent

References

	Year	Citations

Page 1

Page 1